These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3024816)

  • 1. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
    Eisman JA; Barkla DH; Tutton PJ
    Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
    Frampton RJ; Omond SA; Eisman JA
    Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration.
    Thomas GA; Simpson RU
    Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
    Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines.
    Eisman JA; Frampton RJ; McLean FJ
    Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-dihydroxyvitamin D3 and breast cancer.
    Eisman JA; Suva LJ; Frampton RJ
    Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
    Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S; Donaldson CA; Haussler MR
    Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG; Whitlatch LW; Chen TC; Lokeshwar BL; Holick MF
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):391-5. PubMed ID: 9610788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation.
    Sato M; Hiragun A
    J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.
    Lointier P; Wargovich MJ; Saez S; Levin B; Wildrick DM; Boman BM
    Anticancer Res; 1987; 7(4B):817-21. PubMed ID: 2823686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer.
    Berger U; Wilson P; McClelland RA; Colston K; Haussler MR; Pike JW; Coombes RC
    Cancer Res; 1987 Dec; 47(24 Pt 1):6793-9. PubMed ID: 2824042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.